RRFM 2009 Transactions - European Nuclear Society

FiR 1 has an important regional role in producing short lived isotopes as well as in education
and training as there are only a few research reactors in the Baltic region suitable for these
tasks (Fig 3.). FiR 1 is participating the IAEA Baltic Research Reactor Initiative where the
main objective is to evaluate availability and potential of the research reactors in the region to
provide services for neighbouring countries, in particular in the area of education and
training.
7 References
Fig 3. Research reactors in the Baltic region.
[1] Auterinen I, Hiismäki P, Kotiluoto P, et al. Metamorphosis of a 35 years old Triga
reactor into a modern BNCT facility. In: Frontiers in Neutron Capture Therapy.
Hawthorne MF, Shelly K, Wiersema RJ (Eds). Plenum Press, New York, 1: 267-
275, 2001.
[2] Auterinen I. Experience with a modern BNCT facility at the 250 kW FiR Triga
research reactor. Utilization Related Design Features of Research Reactors : A
Compendium. IAEA Technical Reports Series : 455. International Atomic Energy
Agency (IAEA), pp. 253 – 274, 2007.
[3] Joensuu H, Kankaanranta L, Seppälä T et al. Boron neutron capture therapy of
brain tumors: clinical trials at the Finnish facility using boronophenylalanine. Journal
of Neuro-Oncology, vol. 62 (2003), p. 123 - 134.
[4] Kankaanranta L, Seppälä T, Koivunoro H et al. including Kotiluoto P, Auterinen I.
Boron neutron capture therapy in the treatment of locally recurred head and neck
cancer. International Journal of Radiation Oncology Biology Physics, vol. 69, 2, ss.
475 – 482, 2007.
[5] www.boneca.fi
[6] Kuoppamäki R. Flow Measurement Field Calibrations by Radioisotope Tracers in
the Off-shore, Oil and Gas Industry, 24th International North Sea Flow
Measurement Workshop 24th – 25th October 2006.
[7] Törrönen K. Market survey on Boron Neutron Capture Therapy (BNCT) and the
future use of the FiR 1 TRIGA research reactor (report in Finnish), confidential,
Energywave Ltd, Helsinki 2008.
416 of 455